| 000 | 01025 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250516071358.0 | ||
| 264 | 0 | _c20120522 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1873-4286 | ||
| 024 | 7 |
_a10.2174/138161211798764889 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVictor, Victor M | |
| 245 | 0 | 0 |
_aEditorial: new developments in therapy for oxidative stress-related diseases: pathophysiological and clinical consequences. _h[electronic resource] |
| 260 |
_bCurrent pharmaceutical design _cDec 2011 |
||
| 300 |
_a3945-6 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aAging _xdrug effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMetabolic Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 773 | 0 |
_tCurrent pharmaceutical design _gvol. 17 _gno. 36 _gp. 3945-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/138161211798764889 _zAvailable from publisher's website |
| 999 |
_c21409348 _d21409348 |
||